心复宁V号治疗冠心病心绞痛30例—两种症状定量化方法比较

目的我们分别应用三级及五级症状定量化计分方法观察中药组方治疗冠心病心绞痛的疗效，然后对两种症状定量化方法进行比较。方法：两组均采用基础疗法，治疗组30例在应用基础疗法的同时应用心复宁V号（鹿衔草、栝楼、丹参、川芎、桂枝等）治疗，对照组31例在应用基础疗法的同时，应用消心痛治疗。结果A法：治疗组和对照组对冠心病心绞痛中医证侯疗效的总有效率分别为86．67％和61．29％，组间有显著性差异（P〈0．05），治疗组优于对照纽。治疗后心绞痛发作次数组间有显著性差异（P〈0．05），治疗组优于对照组。治疗后症状总积分两组间无显著性差异（P〉0．05），两组疗效相当。B法：治疗组和对照组对冠心病心绞痛中医证侯疗效的总有效率分别为90％和70．97％，组间有显著性差异（P〈0．05），治疗组优于对照组；治疗后心绞痛发作次数组间有显著性差异（P〈0．05），治疗组优于对照组；治疗后症状总积分两组间有显著性差异（P〈0．05），治疗组优于对照组。结论心复宁V号可明显改善心绞痛患者临床症状，控制心绞痛发作。五级症状定量化方法优于三级症状定量化方法。

PindololumV in the Treatment of 30 Cases of Angina Pectoris--Comparison of Two Symptoms Quantification Methods

Objective To observe the effects of traditional Chinese medicine on the treatment of angina pectoris with 3 - rating and 5 - rating symptom scoring methods, and to compare the two methods. Methods Basic therapies were adopted in both groups. 30 cases in the therapeutic group were supplemented with PindololumV （ Herba Pyrolae, Trichosanthes kirilowi, salvia mihiorrhiza, Ligusticum wallichii, Ramulus Cinnamomi, etc. ） 31 cases in the control group were given Isosorbide Dinitrate besides the basic therapy. Results Method A： The total effective rate of angina pectoris TCM syn- dromes of the therapeutic group was 86.67 % , and that of the control group was 61.29%. The difference was significant （ P 〈 0.05 ）, and the result of the therapeutic group was better than that of the control group. There was a marked difference of angina pectoris attacks after the treatment between the two groups, and the therapeutic group proved to be better. The difference of symptom scores of the two groups after the therapy was not significant （ P 〉 0.05 ）, and the effects were similar. Method B ： The total effective rate of angina peetoris TCM syndromes of the therapeutic group was 90 %, and that of the control group was 70.97 %. The difference was significant （ P 〈 0.05 ） , and the result of the therapeutic group was better than that of the control group. There was a marked difference of angina pectoris attacks after the treatment between the two groups, and the therapeutic group proved to be better. The difference of symptom scores of the two groups after the therapy was significant （ P 〉 0.05 ）, and the effect of the therapeutic group was superior to that of the control group. Conclusion PindololumV can obviously improve the clinical symptoms of patients with angina pectoris, and control the attacks. 5 - rating symptom scoring method is superior to 3 - rating symptom scoring method.